Paras, Cecil Joy G.
HRN: 23-17-35 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/29/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/29/2023
07/06/2023
IV
57mg
Q24h
Neonatal Pneumonia
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Pneumonia Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes